Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow796.10 M USD709.30 M USD607.50 M USD692.40 M USD738.60 M USD486.60 M USD713.20 M USD668.90 M USD593.60 M USD509.64 M USD390.97 M USD454.82 M USD
Depreciation & Amortization377.40 M USD375.10 M USD367.70 M USD346.10 M USD309.30 M USD149.90 M USD280.80 M USD275.10 M USD188.40 M USD198.27 M USD191.40 M USD138.20 M USD
Stock-Based Compensation70.50 M USD75.10 M USD62.10 M USD54.20 M USD43.80 M USD37.60 M USD35.10 M USD43.20 M USD37.20 M USD29.86 M USD32.88 M USD36.52 M USD
Capital Expenditures362.40 M USD421.20 M USD392.50 M USD242.00 M USD214.40 M USD310.40 M USD292.10 M USD193.60 M USD127.20 M USD152.64 M USD243.02 M USD238.06 M USD
Cash Flow from Investing-372.90 M USD-764.60 M USD-449.00 M USD-1.83 B USD-450.30 M USD-364.50 M USD-351.30 M USD-1.52 B USD-381.30 M USD-418.78 M USD-287.95 M USD-1.35 B USD
Cash Flow from Financing-425.90 M USD39.20 M USD-173.90 M USD1.19 B USD-311.40 M USD-95.50 M USD-351.40 M USD844.40 M USD-227.90 M USD-1.38 M USD-106.68 M USD842.16 M USD
Dividends Paid0 USD0 USD3.00 M USD3.00 M USD3.00 M USD3.00 M USD3.00 M USD2.90 M USD2.90 M USD2.91 M USD2.91 M USD2.88 M USD
Stock Buybacks290.10 M USD0 USD0 USD78.50 M USD24.80 M USD47.80 M USD156.10 M USD0 USD55.00 M USD0 USD67.30 M USD75.78 M USD
Free Cash Flow433.70 M USD288.10 M USD215.00 M USD450.40 M USD524.20 M USD176.20 M USD421.10 M USD475.30 M USD466.40 M USD357.00 M USD147.95 M USD216.76 M USD

The Cooper Companies, Inc. is a global medical device company focused on eyecare and women’s health, headquartered in San Ramon, California. The business operates through two main segments: CooperVision and CooperSurgical. CooperVision develops, manufactures, and markets a broad portfolio of contact lenses, including spherical, toric, and multifocal designs that address conditions such as myopia, hyperopia, astigmatism, and presbyopia, as well as products aimed at managing ocular dryness and eye fatigue. Its branded lens families, such as Proclear, Biofinity, MyDay, and Clariti, serve eye-care professionals and contact lens wearers worldwide and position the company as a major participant in the soft contact lens market. CooperSurgical provides medical devices, equipment, and consumables for fertility, in vitro fertilization (IVF), and women’s health, supporting clinical workflows across the reproductive care continuum. Within this segment, the company offers products used in assisted reproductive technology, obstetrics, gynecology, and long-acting reversible contraception, making it a notable supplier to hospitals, clinics, and specialty practices focused on women, babies, and family health.